QuickView for PAS fold-3 (biogroup)

1. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts
3. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
4. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
5. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens

There were no matches for PAS fold-3

1. Effectivness of Conservative Techniques in Management of PAS
2. CONVERGE Post-Approval Study (PAS)
3. Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients…
4. Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose…
5. the Efficacy and Safety of the 3-steps Conservative Approach in the Management of Placenta Accreta S…